FDA tentatively OKs Mylan's generic drug combo for HIV

12/1/2011 | Reuters

The FDA, through the President's Emergency Plan for AIDS Relief, tentatively authorized Mylan's second-line HIV therapy comprising ritonavir and atazanavir sulfate. The ingredients are generic forms of Abbott Laboratories' Norvir and Bristol-Myers Squibb's Reyataz, respectively.

View Full Article in:


Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director of Behavioral Health Operations
Meridian Health Plan
Detroit, MI
Medical Director
Bend, OR
Clinical Appeals RN
Brooklyn, NY
Director of Clinical Operations
Meridian Health Plan
Detroit, MI
Sr. Director, Regulatory Compliance Intelligence and Outreach
Johnson & Johnson
New Brunswick, NJ